Suppr超能文献

去甲肾上腺素能阻滞剂在肾上腺切除术治疗嗜铬细胞瘤前的应用:荟萃分析。

Meta-analysis of α-blockade versus no blockade before adrenalectomy for phaeochromocytoma.

机构信息

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany.

Study Centre of the German Surgical Society, University of Heidelberg, Heidelberg, Germany.

出版信息

Br J Surg. 2020 Jan;107(2):e102-e108. doi: 10.1002/bjs.11348.

Abstract

BACKGROUND

Preoperative α-blockade in phaeochromocytoma surgery is recommended by all guidelines to prevent intraoperative cardiocirculatory events. The aim of this meta-analysis was to assess the benefit of such preoperative treatment compared with no treatment before adrenalectomy for phaeochromocytoma.

METHODS

A systematic literature search was undertaken in MEDLINE, Web of Science and CENTRAL without language restrictions. Randomized and non-randomized comparative studies investigating preoperative α-blockade in phaeochromocytoma surgery were included. Data on perioperative safety, effectiveness and outcomes were extracted. Pooled results were calculated as an odds ratio or mean difference with 95 per cent confidence interval.

RESULTS

A total of four retrospective comparative studies were included investigating 603 patients undergoing phaeochromocytoma surgery. Mortality, cardiovascular complications, mean maximal intraoperative systolic and diastolic BP, and mean maximal intraoperative heart rate did not differ between patients with or without α-blockade. The certainty of the evidence was very low owing to the inferior quality of studies.

CONCLUSION

This meta-analysis has shown a lack of evidence for preoperative α-blockade in surgery for phaeochromocytoma. RCTs are needed to evaluate whether preoperative α-blockade can be abandoned.

摘要

背景

所有指南都建议在嗜铬细胞瘤手术中进行术前α阻断治疗,以预防术中心血管事件。本荟萃分析的目的是评估与肾上腺切除术前不治疗相比,这种术前治疗对嗜铬细胞瘤的益处。

方法

系统检索了 MEDLINE、Web of Science 和 CENTRAL 数据库,无语言限制。纳入了研究嗜铬细胞瘤手术中术前α阻断治疗的随机和非随机对照研究。提取围手术期安全性、有效性和结局数据。汇总结果以优势比或均数差及 95%置信区间表示。

结果

共纳入四项回顾性比较研究,涉及 603 例接受嗜铬细胞瘤手术的患者。死亡率、心血管并发症、术中最大收缩压和舒张压的平均最大值以及术中最大心率的平均最大值在接受或不接受α阻断治疗的患者之间无差异。由于研究质量较差,证据的确定性非常低。

结论

本荟萃分析表明,嗜铬细胞瘤手术中术前α阻断治疗缺乏证据。需要进行 RCT 来评估是否可以放弃术前α阻断治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验